Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
1985 2
1993 2
1994 2
1995 4
1996 1
1997 1
1998 1
1999 1
2000 2
2001 1
2002 3
2006 2
2007 1
2008 1
2013 1
2015 1
2016 3
2017 1
2018 1
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of congenital fibrinogen disorders.
Lebreton A, Casini A. Lebreton A, et al. Ann Biol Clin (Paris). 2016 Aug 1;74(4):405-12. doi: 10.1684/abc.2016.1167. Ann Biol Clin (Paris). 2016. PMID: 27492693 Free article. Review. English.
All the coagulation tests that depend on the formation of fibrin as the end point are affected; although in dysfibrinogenemia the specificity and sensitivity of routine test depend on reagent and techniques. ...Homozygous or composite heterozygous null mutations are most o …
All the coagulation tests that depend on the formation of fibrin as the end point are affected; although in dysfibrinogenemia the spe …
Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
Yan J, Luo M, Xiang L, Wu Y, Lin F. Yan J, et al. Clin Chim Acta. 2022 Mar 1;528:1-5. doi: 10.1016/j.cca.2022.01.009. Epub 2022 Jan 19. Clin Chim Acta. 2022. PMID: 35063457 Review.
The clinical manifestations are high heterogeneity. Treatment for dysfibrinogenemia should be personalized. Here, we reported four congenital dysfibrinogenemia patients with the major surgery, in order to discuss the treatment and diagnosis of congenital dysfibri …
The clinical manifestations are high heterogeneity. Treatment for dysfibrinogenemia should be personalized. Here, we reported four co …
Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F, Samama M. Haverkate F, et al. Thromb Haemost. 1995 Jan;73(1):151-61. Thromb Haemost. 1995. PMID: 7740487 Review.
Twenty-six cases fulfilled the (arbitrarily chosen) criteria of familial dysfibrinogenemia and of thrombosis not due to other causes. ...Analysis of 187 investigated family members showed that thrombophilia affected 20 persons exclusively in the group of 99 r …
Twenty-six cases fulfilled the (arbitrarily chosen) criteria of familial dysfibrinogenemia and of thrombosis not due to other …
Laboratory diagnosis of dysfibrinogenemia.
Cunningham MT, Brandt JT, Laposata M, Olson JD. Cunningham MT, et al. Arch Pathol Lab Med. 2002 Apr;126(4):499-505. doi: 10.5858/2002-126-0499-LDOD. Arch Pathol Lab Med. 2002. PMID: 11900586 Free article. Review.
The inherited form is associated with increased risk of bleeding, thrombosis, or both in the same patient or family. Traditionally, dysfibrinogenemia is diagnosed by abnormal tests of fibrin clot formation; the thrombin time and reptilase time are the screening test …
The inherited form is associated with increased risk of bleeding, thrombosis, or both in the same patient or family. Traditionally, …
Clinical Features and Management of Congenital Fibrinogen Deficiencies.
Casini A, de Moerloose P, Neerman-Arbez M. Casini A, et al. Semin Thromb Hemost. 2016 Jun;42(4):366-74. doi: 10.1055/s-0036-1571339. Epub 2016 Mar 28. Semin Thromb Hemost. 2016. PMID: 27019462 Review.
Congenital fibrinogen disorders are rare diseases affecting either the quantity (afibrinogenemia and hypofibrinogenemia) or the quality (dysfibrinogenemia) or both (hypodysfibrinogenemia) of plasmatic fibrinogen. ...More specifically, management strategies should be tailor …
Congenital fibrinogen disorders are rare diseases affecting either the quantity (afibrinogenemia and hypofibrinogenemia) or the quality ( …
Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding.
Bor MV, Feddersen S, Pedersen IS, Sidelmann JJ, Kristensen SR. Bor MV, et al. Semin Thromb Hemost. 2022 Mar;48(2):161-173. doi: 10.1055/s-0041-1730358. Epub 2021 Jul 14. Semin Thromb Hemost. 2022. PMID: 34261148 Review.
Dysfibrinogenemias related to residues Gly17, Pro18, and Val20 are exclusively associated with bleeding tendency. ...To elaborate the genotype-phenotype associations further, we studied a Danish family with knob A-related dysfibrinogenemia caused by the Aalph …
Dysfibrinogenemias related to residues Gly17, Pro18, and Val20 are exclusively associated with bleeding tendency. ...To elaborate the …
Can the phenotype of inherited fibrinogen disorders be predicted?
Casini A, de Moerloose P. Casini A, et al. Haemophilia. 2016 Sep;22(5):667-75. doi: 10.1111/hae.12967. Epub 2016 Jun 13. Haemophilia. 2016. PMID: 27293018 Review.
Clinical manifestations of dysfibrinogenaemia include absence of symptoms, major bleeding or thrombosis as well as systemic amyloidosis. ...Improving accuracy of diagnosis, performing genotype, analysing function of fibrinogen variants and carefully investigating the perso …
Clinical manifestations of dysfibrinogenaemia include absence of symptoms, major bleeding or thrombosis as well as systemic amyloidos …
Laboratory investigation of thrombophilia.
Tripodi A, Mannucci PM. Tripodi A, et al. Clin Chem. 2001 Sep;47(9):1597-606. Clin Chem. 2001. PMID: 11514392 Review.
Until recently, laboratory diagnosis of thrombophilia was based on investigation of the plasmatic anticoagulant pathways to detect antithrombin, protein C, and protein S deficiencies and on the search for dysfibrinogenemia and anti-phospholipid antibodies/lupus anticoagula …
Until recently, laboratory diagnosis of thrombophilia was based on investigation of the plasmatic anticoagulant pathways to detect antithrom …
The hypercoagulable states.
Schafer AI. Schafer AI. Ann Intern Med. 1985 Jun;102(6):814-28. doi: 10.7326/0003-4819-102-6-814. Ann Intern Med. 1985. PMID: 3158262 Review.
These disorders are generally inherited abnormalities of coagulation in which a physiologic anticoagulant mechanism is defective: for example, antithrombin III deficiency, protein C and protein S deficiency, abnormalities of the fibrinolytic system, and dysfibrinogenemias. …
These disorders are generally inherited abnormalities of coagulation in which a physiologic anticoagulant mechanism is defective: for exampl …
Inherited thrombophilia and fetal loss.
Brenner B. Brenner B. Curr Opin Hematol. 2000 Sep;7(5):290-5. doi: 10.1097/00062752-200009000-00006. Curr Opin Hematol. 2000. PMID: 10961579 Review.
This review focuses on association of fetal loss with inherited thrombophilias, including dysfibrinogenemia and protein C, protein S, and antithrombin III deficiencies. ...
This review focuses on association of fetal loss with inherited thrombophilias, including dysfibrinogenemia and protein C, protein S, …
37 results